Effects of endothelin on regional blood flows in squirrel monkeys
- PMID: 2674417
Effects of endothelin on regional blood flows in squirrel monkeys
Abstract
Endothelin is a newly described potent vasoconstrictor produced by endothelial cells. The aim of the present study was to evaluate the effects of i.v. injection of human endothelin on regional blood flows (RBFs) and hemodynamic parameters in nonhuman primates. For this purpose, in a first series of experiments, anesthetized squirrel monkeys were instrumented with Doppler flow-probes in order to measure RBF continuously in the renal, mesenteric and iliac vascular beds. Endothelin at 0.03 and 0.1 microgram/kg produced no effect. After 0.3 and 1 microgram/kg, renal and mesenteric blood flow decreased, but iliac blood flow increased transiently. With 3 micrograms/kg all the three vascular beds were constricted. In the kidney, blood flow was almost abolished and the effect of endothelin sustained for up to 2 hr and more. In a second series of experiments, radioactive microspheres were used to measure RBFs in most organs 3 to 4 min after endothelin (0.3, 1 and 3 microgram/kg), or after vehicle alone. Endothelin induced a dose-dependent increase in systemic vascular resistance and increase in mean arterial blood pressure. The vasoconstrictor effect was selective for some vascular beds. The splanchnic vascular bed (except stomach) was most affected, with a 96% decrease in renal and splenic blood flow after 3 micrograms/kg of endothelin. The coronary blood flow decreased by 46% after 3 micrograms/kg, with a greater effect in subepicardium than subendocardium. In contrast, the blood flow to the brain and stomach was not decreased by endothelin. We conclude that endothelin is a potent vasoconstrictor in squirrel monkeys selective for some vascular beds.
Similar articles
-
Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.Br J Pharmacol. 1997 Mar;120(6):1101-13. doi: 10.1038/sj.bjp.0701022. Br J Pharmacol. 1997. PMID: 9134223 Free PMC article.
-
Regional and systemic hemodynamic effects of parathyroid hormone-related protein: preservation of cardiac function and coronary and renal flow with reduced blood pressure.J Pharmacol Exp Ther. 1991 Jan;256(1):110-8. J Pharmacol Exp Ther. 1991. PMID: 1988652
-
Effects of glucagon on regional blood flow during cardiogenic shock.Circ Shock. 1979;6(4):365-73. Circ Shock. 1979. PMID: 119586
-
Generalized cardiovascular and regional hemodynamic effects of meperidine in conscious dogs.Anesth Analg. 1981 Sep;60(9):649-54. Anesth Analg. 1981. PMID: 7196709
-
Acute effects of bunazosin on aortic, vertebral, coronary and renal blood flows of anesthetized dogs.Arzneimittelforschung. 1986 Aug;36(8):1202-5. Arzneimittelforschung. 1986. PMID: 2877674
Cited by
-
Therapeutic role of bosentan in hypertension: lessons from the model of perinephritic hypertension.Heart Fail Rev. 2001 Dec;6(4):253-64. doi: 10.1023/a:1011419223152. Heart Fail Rev. 2001. PMID: 11447300 Review.
-
Regulation of blood pressure and salt homeostasis by endothelin.Physiol Rev. 2011 Jan;91(1):1-77. doi: 10.1152/physrev.00060.2009. Physiol Rev. 2011. PMID: 21248162 Free PMC article. Review.
-
Ovarian hormones modulate endothelin A and B receptor expression.Life Sci. 2016 Aug 15;159:148-152. doi: 10.1016/j.lfs.2016.01.010. Epub 2016 Jan 8. Life Sci. 2016. PMID: 26776836 Free PMC article.
-
Endothelin and myocardial ischemia.Cardiovasc Drugs Ther. 1994 Aug;8(4):589-99. doi: 10.1007/BF00877413. Cardiovasc Drugs Ther. 1994. PMID: 7848895 Review.
-
Endothelin in heart failure.Curr Hypertens Rep. 1999 Feb-Mar;1(1):62-8. doi: 10.1007/s11906-999-0075-9. Curr Hypertens Rep. 1999. PMID: 10981044 Review.